Palisade Bio, Inc.
PALI
$1.66
-$0.17-9.30%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.53M | 1.17M | 1.36M | 1.30M | 1.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.92M | 2.84M | 2.31M | 3.38M | 3.59M |
| Operating Income | -2.92M | -2.84M | -2.31M | -3.38M | -3.59M |
| Income Before Tax | -2.87M | -2.78M | -2.23M | -3.34M | -3.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.87M | -2.78M | -2.23M | -3.34M | -3.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.87M | -2.78M | -2.23M | -3.34M | -3.49M |
| EBIT | -2.92M | -2.84M | -2.31M | -3.38M | -3.59M |
| EBITDA | -2.92M | -2.84M | -2.31M | -3.38M | -3.59M |
| EPS Basic | -0.38 | -0.58 | -0.47 | -1.55 | -2.32 |
| Normalized Basic EPS | -0.24 | -0.36 | -0.29 | -0.97 | -1.45 |
| EPS Diluted | -0.38 | -0.58 | -0.47 | -1.55 | -2.32 |
| Normalized Diluted EPS | -0.24 | -0.36 | -0.29 | -0.97 | -1.45 |
| Average Basic Shares Outstanding | 7.47M | 4.80M | 4.80M | 2.16M | 1.50M |
| Average Diluted Shares Outstanding | 7.47M | 4.80M | 4.80M | 2.16M | 1.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |